Jonathan David Schwartz - May 16, 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Chief Medical & Gene Therapy Officer
Signature
/s/ Martin Wilson, as attorney-in-fact for Jonathan David Schwartz
Stock symbol
RCKT
Transactions as of
May 16, 2025
Transactions value $
-$10,327
Form type
4
Date filed
5/20/2025, 04:05 PM
Previous filing
Feb 13, 2025
Next filing
May 22, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schwartz Jonathan David Chief Medical & Gene Therapy Officer C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for Jonathan David Schwartz 2025-05-20 0001726398

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale -$10.3K -1.58K -0.67% $6.53 236K May 16, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

Remarks:

Chief Medical & Gene Therapy Officer